[HTML][HTML] Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert�…

S Rossi, A Antal, S Bestmann, M Bikson, C Brewer…�- Clinical�…, 2021 - Elsevier
This article is based on a consensus conference, promoted and supported by the
International Federation of Clinical Neurophysiology (IFCN), which took place in Siena (Italy)�…

[HTML][HTML] Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential

L Gao, Y Zhang, K Sterling, W Song�- Translational neurodegeneration, 2022 - Springer
Synaptic abnormalities are a cardinal feature of Alzheimer's disease (AD) that are known to
arise as the disease progresses. A growing body of evidence suggests that pathological�…

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)

JP Lefaucheur, N Andr�-Obadia, A Antal…�- Clinical�…, 2014 - Elsevier
A group of European experts was commissioned to establish guidelines on the therapeutic
use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until�…

Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial

G Koch, EP Casula, S Bonn�, I Borghi, M Assogna…�- Brain, 2022 - academic.oup.com
Repetitive transcranial magnetic stimulation (rTMS) is emerging as a non-invasive
therapeutic strategy in the battle against Alzheimer's disease. Alzheimer's disease patients�…

[HTML][HTML] The role of the dorsolateral prefrontal cortex for speech and language processing

I Hertrich, S Dietrich, C Blum…�- Frontiers in human�…, 2021 - frontiersin.org
This review article summarizes various functions of the dorsolateral prefrontal cortex
(DLPFC) that are related to language processing. To this end, its connectivity with the left�…

[HTML][HTML] Novel therapeutic approaches for Alzheimer's disease: an updated review

TW Yu, HY Lane, CH Lin�- International journal of molecular sciences, 2021 - mdpi.com
Alzheimer's disease (AD) is a progressive neurodegenerative disease and accounts for
most cases of dementia. The prevalence of AD has increased in the current rapidly aging�…

A systematic review and meta-analysis of rTMS effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease

Y Chou, VT That, M Sundman�- Neurobiology of aging, 2020 - Elsevier
Repetitive transcranial magnetic stimulation (rTMS), a noninvasive brain stimulation
technique, has emerged as a promising treatment for mild cognitive impairment (MCI) and�…

Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia

V Di Lazzaro, R Bella, A Benussi, M Bologna…�- Clinical�…, 2021 - Elsevier
Transcranial magnetic stimulation (TMS) is a powerful tool to probe in vivo brain circuits, as it
allows to assess several cortical properties such as excitability, plasticity and connectivity in�…

[HTML][HTML] Transcranial magnetic stimulation in the treatment of neurological diseases

FA Somaa, TA de Graaf, AT Sack�- Frontiers in Neurology, 2022 - frontiersin.org
Transcranial Magnetic Stimulation (TMS) has widespread use in research and clinical
application. For psychiatric applications, such as depression or OCD, repetitive TMS�…

Neural oscillations and brain stimulation in Alzheimer's disease

Z Jafari, BE Kolb, MH Mohajerani�- Progress in neurobiology, 2020 - Elsevier
Aging is associated with alterations in cognitive processing and brain neurophysiology.
Whereas the primary symptom of amnestic mild cognitive impairment (aMCI) is memory�…